TOI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Oncology Institute Inc (TOI).


$23.35M Market Cap.

As of 03/26/2025 5:00 PM ET (MRY) • Disclaimer

TOI Market Cap. (MRY)


TOI Shares Outstanding (MRY)


TOI Assets (MRY)


Total Assets

$172.72M

Total Liabilities

$169.13M

Total Investments

$0

TOI Income (MRY)


Revenue

$393.41M

Net Income

-$64.66M

Operating Expense

$114.11M

TOI Cash Flow (MRY)


CF Operations

-$26.54M

CF Investing

$46.21M

CF Financing

-$3.49M

TOI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

-

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TOI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$172,717,000 (-17.46%)

$209,240,000 (-20.04%)

$261,665,000 (28.62%)

$203,439,000 (209.70%)

Assets Current

$112,418,000 (-21.66%)

$143,493,000 (10.03%)

$130,418,000 (-15.34%)

$154,056,000 (418.36%)

Assets Non-Current

$60,299,000 (-8.29%)

$65,747,000 (-49.91%)

$131,247,000 (165.77%)

$49,383,000 (37.29%)

Goodwill & Intangible Assets

$22,040,000 (-12.31%)

$25,134,000 (-36.17%)

$39,375,000 (-12.25%)

$44,871,000 (32.98%)

Shareholders Equity

$3,589,000 (-93.71%)

$57,025,000 (-53.70%)

$123,175,000 (18.26%)

$104,159,000 (270.66%)

Property Plant & Equipment Net

$37,670,000 (-5.95%)

$40,052,000 (21.22%)

$33,041,000 (688.19%)

$4,192,000 (99.24%)

Cash & Equivalents

$49,669,000 (48.32%)

$33,488,000 (139.03%)

$14,010,000 (-87.84%)

$115,174,000 (1820.21%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$49,367,000 (-58.22%)

$118,150,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$49,367,000 (-17.44%)

$59,796,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$58,354,000 (0%)

$0 (0%)

Inventory

$10,039,000 (-26.60%)

$13,678,000 (47.69%)

$9,261,000 (43.85%)

$6,438,000 (47.86%)

Trade & Non-Trade Receivables

$48,681,000 (13.45%)

$42,911,000 (6.13%)

$40,433,000 (90.33%)

$21,244,000 (23.09%)

Trade & Non-Trade Payables

$24,324,000 (68.58%)

$14,429,000 (53.96%)

$9,372,000 (-39.76%)

$15,559,000 (23.06%)

Accumulated Retained Earnings (Deficit)

-$210,813,000 (-44.24%)

-$146,150,000 (-131.68%)

-$63,082,000 (0.24%)

-$63,234,000 (-20.89%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$32,000 (0.00%)

$32,000 (-91.18%)

$363,000 (-27.83%)

$503,000 (-81.76%)

Total Debt

$123,152,000 (2.91%)

$119,675,000 (10.63%)

$108,179,000 (59014.21%)

$183,000 (-98.47%)

Debt Current

$6,798,000 (6.84%)

$6,363,000 (15.73%)

$5,498,000 (2904.37%)

$183,000 (-96.59%)

Debt Non-Current

$116,354,000 (2.68%)

$113,312,000 (10.35%)

$102,681,000 (0%)

$0 (0%)

Total Liabilities

$169,128,000 (11.11%)

$152,215,000 (9.91%)

$138,490,000 (39.49%)

$99,280,000 (164.13%)

Liabilities Current

$52,215,000 (50.09%)

$34,788,000 (17.05%)

$29,720,000 (-0.26%)

$29,798,000 (4.16%)

Liabilities Non-Current

$116,913,000 (-0.44%)

$117,427,000 (7.96%)

$108,770,000 (56.54%)

$69,482,000 (673.66%)

TOI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$393,412,000 (21.33%)

$324,239,000 (28.42%)

$252,483,000 (24.37%)

$203,003,000 (8.26%)

Cost of Revenue

$339,415,000 (28.24%)

$264,666,000 (32.08%)

$200,390,000 (23.58%)

$162,155,000 (7.65%)

Selling General & Administrative Expense

$107,828,000 (-5.29%)

$113,851,000 (-4.88%)

$119,689,000 (43.57%)

$83,365,000 (98.97%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$114,115,000 (-16.45%)

$136,591,000 (1.90%)

$134,044,000 (54.60%)

$86,706,000 (92.36%)

Interest Expense

$7,496,000 (10.61%)

$6,777,000 (66.02%)

$4,082,000 (1175.63%)

$320,000 (-7.78%)

Income Tax Expense

$0 (0%)

-$36,000 (85.19%)

-$243,000 (63.79%)

-$671,000 (-36.11%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$64,663,000 (22.16%)

-$83,068,000 (-54750.00%)

$152,000 (101.39%)

-$10,927,000 (23.70%)

Net Income to Non-Controlling Interests

$0 (0%)

-$15,191,000 (-18184.52%)

$84,000 (128.09%)

-$299,000 (0%)

Net Income

-$64,663,000 (4.74%)

-$67,877,000 (-99919.12%)

$68,000 (100.64%)

-$10,628,000 (25.79%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$64,663,000 (4.74%)

-$67,877,000 (-99919.12%)

$68,000 (100.64%)

-$10,628,000 (25.79%)

Weighted Average Shares

$75,043,678 (1.76%)

$73,748,660 (1.31%)

$72,793,497 (9.91%)

$66,230,606 (12.03%)

Weighted Average Shares Diluted

$75,043,678 (1.76%)

$73,748,660 (-8.51%)

$80,605,600 (21.70%)

$66,230,606 (12.03%)

Earning Before Interest & Taxes (EBIT)

-$57,167,000 (6.49%)

-$61,136,000 (-1664.78%)

$3,907,000 (135.59%)

-$10,979,000 (24.12%)

Gross Profit

$53,997,000 (-9.36%)

$59,573,000 (14.36%)

$52,093,000 (27.53%)

$40,848,000 (10.76%)

Operating Income

-$60,118,000 (21.94%)

-$77,018,000 (6.02%)

-$81,951,000 (-78.71%)

-$45,858,000 (-459.45%)

TOI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$46,211,000 (-26.23%)

$62,640,000 (147.59%)

-$131,614,000 (-982.89%)

-$12,154,000 (-37.43%)

Net Cash Flow from Financing

-$3,492,000 (49.00%)

-$6,847,000 (-107.43%)

$92,206,000 (-40.13%)

$154,010,000 (1195.51%)

Net Cash Flow from Operations

-$26,538,000 (26.92%)

-$36,315,000 (41.20%)

-$61,756,000 (-88.97%)

-$32,680,000 (-6533.07%)

Net Cash Flow / Change in Cash & Cash Equivalents

$16,181,000 (-16.93%)

$19,478,000 (119.25%)

-$101,164,000 (-192.66%)

$109,176,000 (2973.65%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$4,456,000 (48.05%)

-$8,577,000 (7.84%)

-$9,307,000 (-6104.67%)

Net Cash Flow - Investment Acquisitions and Disposals

$50,000,000 (-30.23%)

$71,663,000 (160.99%)

-$117,508,000 (0%)

$0 (0%)

Capital Expenditure

-$3,789,000 (17.04%)

-$4,567,000 (17.40%)

-$5,529,000 (-94.20%)

-$2,847,000 (-138.44%)

Issuance (Repayment) of Debt Securities

-$1,195,000 (64.54%)

-$3,370,000 (-103.33%)

$101,270,000 (13069.05%)

$769,000 (-93.69%)

Issuance (Purchase) of Equity Shares

$75,000 (108.40%)

-$893,000 (89.03%)

-$8,142,000 (-102.44%)

$333,946,000 (667792.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$11,152,000 (-37.38%)

$17,810,000 (-35.66%)

$27,683,000 (12.83%)

$24,535,000 (16148.34%)

Depreciation Amortization & Accretion

$6,287,000 (7.05%)

$5,873,000 (33.14%)

$4,411,000 (32.03%)

$3,341,000 (5.13%)

TOI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

13.70% (-25.54%)

18.40% (-10.68%)

20.60% (2.49%)

20.10% (2.03%)

Profit Margin

-16.40% (21.53%)

-20.90% (0%)

0% (0%)

-5.20% (31.58%)

EBITDA Margin

-12.90% (24.12%)

-17.00% (-615.15%)

3.30% (186.84%)

-3.80% (36.67%)

Return on Average Equity (ROAE)

-288.80% (-231.95%)

-87.00% (-87100.00%)

0.10% (100.62%)

-16.10% (87.89%)

Return on Average Assets (ROAA)

-35.10% (-15.46%)

-30.40% (0%)

0% (0%)

-7.90% (-5.33%)

Return on Sales (ROS)

-14.50% (23.28%)

-18.90% (-1360.00%)

1.50% (127.78%)

-5.40% (29.87%)

Return on Invested Capital (ROIC)

-29.30% (-22.08%)

-24.00% (-1100.00%)

2.40% (102.52%)

-95.30% (-1048.19%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

0 (0%)

-2.22

-

-60.94 (-35.42%)

Price to Sales Ratio (P/S)

0.06 (-87.28%)

0.46 (-2.52%)

0.48 (-85.04%)

3.18 (-6.58%)

Price to Book Ratio (P/B)

6.5 (146.59%)

2.64 (172.24%)

0.97 (-85.87%)

6.86 (-37.94%)

Debt to Equity Ratio (D/E)

47.12 (1665.61%)

2.67 (137.46%)

1.12 (17.94%)

0.95 (-28.77%)

Earnings Per Share (EPS)

-53,005 (-5761313.04%)

-0.92 (0%)

0 (0%)

-0.16 (33.33%)

Sales Per Share (SPS)

5.24 (19.22%)

4.4 (26.79%)

3.47 (13.15%)

3.06 (-3.37%)

Free Cash Flow Per Share (FCFPS)

-0.4 (27.08%)

-0.55 (40.04%)

-0.92 (-72.39%)

-0.54 (-4366.67%)

Book Value Per Share (BVPS)

0.05 (-93.79%)

0.77 (-54.31%)

1.69 (7.57%)

1.57 (231.16%)

Tangible Assets Book Value Per Share (TABVPS)

2.01 (-19.55%)

2.5 (-18.27%)

3.05 (27.57%)

2.39 (343.33%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (50.00%)

-4 (-109.52%)

42 (165.63%)

-64 (-204.76%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.94 (55.29%)

-4.35 (-122.05%)

19.72 (121.39%)

-92.16 (-236.16%)

Asset Turnover

2.14 (47.04%)

1.45 (35.63%)

1.07 (-28.96%)

1.51 (53.04%)

Current Ratio

2.15 (-47.81%)

4.13 (-5.99%)

4.39 (-15.13%)

5.17 (397.59%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$30,327,000 (25.82%)

-$40,882,000 (39.24%)

-$67,285,000 (-89.39%)

-$35,527,000 (-5078.86%)

Enterprise Value (EV)

$98,895,754 (-58.84%)

$240,259,917 (46.50%)

$163,998,784 (-76.70%)

$703,887,302 (127.43%)

Earnings Before Tax (EBT)

-$64,663,000 (4.79%)

-$67,913,000 (-38707.43%)

-$175,000 (98.45%)

-$11,299,000 (23.73%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$50,880,000 (7.93%)

-$55,263,000 (-764.38%)

$8,318,000 (208.90%)

-$7,638,000 (32.35%)

Invested Capital

$171,945,000 (-26.99%)

$235,505,000 (-17.87%)

$286,739,000 (1980.99%)

$13,779,000 (48.64%)

Working Capital

$60,203,000 (-44.62%)

$108,705,000 (7.95%)

$100,698,000 (-18.96%)

$124,258,000 (11064.24%)

Tangible Asset Value

$150,677,000 (-18.16%)

$184,106,000 (-17.18%)

$222,290,000 (40.19%)

$158,568,000 (396.36%)

Market Capitalization

$23,347,754 (-84.48%)

$150,447,917 (26.04%)

$119,363,784 (-83.29%)

$714,178,160 (130.01%)

Average Equity

$22,393,250 (-71.29%)

$78,000,500 (-38.47%)

$126,772,500 (91.70%)

$66,130,000 (513.72%)

Average Assets

$184,008,500 (-17.50%)

$223,046,250 (-5.26%)

$235,429,750 (74.96%)

$134,564,000 (-29.21%)

Invested Capital Average

$195,196,000 (-23.48%)

$255,091,250 (59.13%)

$160,308,250 (1291.02%)

$11,524,500 (-93.41%)

Shares

75,559,075 (2.45%)

73,748,979 (1.95%)

72,341,687 (-1.24%)

73,249,042 (154.78%)